Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762760 · ClinicalTrials.gov registry record · Phase 1
AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint
A Phase 1 study of Osteoarthritis of the Hand, sponsored by Ampio Pharmaceuticals..
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02762760: Completed Phase 1 study of Osteoarthritis of the Hand, sponsored by Ampio Pharmaceuticals..
NCT02762760 is a Phase 1 study of Osteoarthritis of the Hand that has completed, run by Ampio Pharmaceuticals.. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02762760, a Phase 1 study of Osteoarthritis of the Hand, has completed, sponsored by Ampio Pharmaceuticals..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the basal thumb joint.
Primary Outcome
The Clinical safety of treatment on base of the thumb will be assessed by recording AEs at all in-clinic visits and the 24-hour, post-injection telephone contact call, by the results of the physical examination of the thumb joint and vital signs (at all in-clinic visits), and by recording prior and concomitant medications including start/stop dates, indication, dose and frequency (at 24 hour post-injection telephone contact call and all in-clinic visits).
Conditions Studied
Interventions
- BIOLOGICAL Saline
- BIOLOGICAL AMPION™
Study Locations (1)
Colorado
- Ampio Pharmaceuticals - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
What the finished NCT02762760 record still lists
NCT02762760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Osteoarthritis of the Hand appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT02762760 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02762760 about?
NCT02762760 is a clinical study titled "AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint". This study will evaluate the safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the basal thumb joint.
What is the current status of trial NCT02762760?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2016-11.
What conditions does trial NCT02762760 study?
This clinical trial studies the following conditions: Osteoarthritis of the Hand.
What interventions are being tested in trial NCT02762760?
The interventions under investigation include: Saline (BIOLOGICAL), AMPION™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT02762760?
This trial is sponsored by Ampio Pharmaceuticals., which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02762760 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02762760's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia